Investments

Co-Investment
Held / Exited
  •  MARLINK-logo
    Co-Investment

    Marlink

    France

    Technology, Media and Telecom
    Technology, Media and Telecom

    Founded in 2007 and based in Paris, Marlink is a leading provider of satellite connectivity with #1 position globally in the Maritime industry and #1 in EMEA for Enterprise customers. It employs c.970 FTEs and has an international presence with 27 global teleports.

  • Questel logo
    Co-Investment

    Questel

    France

    Technology, Media and Telecom
    Technology, Media and Telecom

    Founded in 1978, Questel is a global leader in intellectual property (IP) software and tech-enabled solutions. Headquartered in Paris and employer of more than 900 FTEs globally, Questel offers a comprehensive suite of software and complementary tech-enabled solutions to cover the needs of corporates’ R&D and legal departments, law firms and universities in terms of IP. The company has also been able to enlarge its product offering, evolving towards a one-stop-shop offer covering the full lifecycle of an IP.

  • Logo Solina
    Co-Investment

    Solina

    France

    Consumer goods and services
    Consumer goods and services

    Solina is the leading European manufacturer of ingredient and seasoning blends serving over 18,000 customers in the food industry. Solina designs, hand in hand with its clients, blends that improve the taste and production process of their products. Solina has leading positions in the countries it operates in, resulting from superior customer service and R&D capabilities. The company puts sustainability at the centre of its activities by creating healthier food solutions and more sustainable diets as well as by contributing to the development of meat-alternatives.

  • Recipharm logo
    Co-Investment

    Recipharm

    Sweden

    Healthcare & life science
    Healthcare & life science

    Founded in 1995 and headquartered in Stockholm, Recipharm is the #2 largest European Contract Development and Manufacturing Organization and #5 globally. It operates more than 30 facilities and employs more than 9,000 people. Recipharm focuses on the manufacturing of solids, steriles and respiratory drugs and devices (Advanced Delivery Systems).

The Ardian team brought a deep sector knowledge, which I think allowed them not only to do a terrific job in that due diligence period, but also meant they could work very efficiently within our deal time frame.

Doug Brody KKR Capital Market

Ardian and Arsenal both want our investments to benefit society and by working together in this case we’ve reduced the time it takes to set up a clinical trial by many months, which means new drugs come to market as quickly and safely as possible.

Steve McLean Partner of Arsenal Capital

During the due diligence phase, we identified Ardian as a future shareholder capable of making a significant contribution to Emera's development. As soon as the transaction closed, we were able to define and launch value-creating initiatives with Naxicap and Ardian, particularly in terms of group structuring, external growth, digital transformation and real estate strategy, in France but also in Spain and other European countries.

Eric Baugas CEO of EMERA